• Create BookmarkCreate Bookmark
  • Create Note or TagCreate Note or Tag
  • PrintPrint
Share this Page URL
Help

Chapter 17. Growth Investing: The Process > Step 6: Management Quality

Step 6: Management Quality

Key Executive and Board Quality

Impath's CEO had been with the company since 1990, and prior to that was a prominent academic researcher in the same field. Two other key officers had been with the company since the early 1990s.

Impath's CEO was board chairman. One Impath board member was a former vice chairman of the board of Johnson & Johnson, and had held numerous other prestigious positions. Another board member was an Impath cofounder and is a prominent pathologist. The third board member was the dean of an applied life sciences school and a cofounder and CEO of a biological life sciences firm. The fourth board member was the CEO of a medical research firm. The fifth board member was vice president of a unit of Bristol-Meyers Squibb. Only one board member, an attorney, was not actively involved in the medical profession.


PREVIEW

                                                                          

Not a subscriber?

Start A Free Trial


  
  • Creative Edge
  • Create BookmarkCreate Bookmark
  • Create Note or TagCreate Note or Tag
  • PrintPrint